GALVANI, FRANCESCA
GALVANI, FRANCESCA
Dipartimento di Scienze degli Alimenti e del Farmaco
Development of potent and selective FAAH inhibitors with improved drug-like properties as potential tools to treat neuroinflammatory conditions
2023-01-01 Papa, A.; Pasquini, S.; Galvani, F.; Cammarota, M.; Contri, C.; Carullo, G.; Gemma, S.; Ramunno, A.; Lamponi, S.; Gorelli, B.; Saponara, S.; Varani, K.; Mor, M.; Campiani, G.; Boscia, F.; Vincenzi, F.; Lodola, A.; Butini, S.
Mechanistic Modeling of Lys745 Sulfonylation in EGFR C797S Reveals Chemical Determinants for Inhibitor Activity and Discriminates Reversible from Irreversible Agents
2023-01-01 Arafet, Kemel; Scalvini, Laura; Galvani, Francesca; Martí, Sergio; Moliner, Vicent; Mor, Marco; Lodola, Alessio
Mechanistic Modeling of Monoglyceride Lipase Covalent Modification Elucidates the Role of Leaving Group Expulsion and Discriminates Inhibitors with High and Low Potency
2022-01-01 Galvani, F.; Scalvini, L.; Rivara, S.; Lodola, A.; Mor, M.
Molecular Determinants of EphA2 and EphB2 Antagonism Enable the Design of Ligands with Improved Selectivity
2023-01-01 Guidetti, Lorenzo; Zappia, Alfonso; Scalvini, Laura; Ferrari, Francesca Romana; Giorgio, Carmine; Castelli, Riccardo; Galvani, Francesca; Vacondio, Federica; Rivara, Silvia; Mor, Marco; Urbinati, Chiara; Rusnati, Marco; Tognolini, Massimiliano; Lodola, Alessio
Pharmacological characterization of second generation FXR agonists as effective EphA2 antagonists: A successful application of target hopping approach
2023-01-01 Ferrari, Francesca Romana; Giorgio, Carmine; Zappia, Alfonso; Ballabeni, Vigilio; Bertoni, Simona; Barocelli, Elisabetta; Scalvini, Laura; Galvani, Francesca; Mor, Marco; Lodola, Alessio; Tognolini, Massimiliano
Unbinding Kinetics of Muscarinic M3 Receptor Antagonists Explained by Metadynamics Simulations
2023-01-01 Galvani, F.; Pala, D.; Cuzzolin, A.; Scalvini, L.; Lodola, A.; Mor, M.; Rizzi, A.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Development of potent and selective FAAH inhibitors with improved drug-like properties as potential tools to treat neuroinflammatory conditions | 1-gen-2023 | Papa, A.; Pasquini, S.; Galvani, F.; Cammarota, M.; Contri, C.; Carullo, G.; Gemma, S.; Ramunno, A.; Lamponi, S.; Gorelli, B.; Saponara, S.; Varani, K.; Mor, M.; Campiani, G.; Boscia, F.; Vincenzi, F.; Lodola, A.; Butini, S. | |
| Mechanistic Modeling of Lys745 Sulfonylation in EGFR C797S Reveals Chemical Determinants for Inhibitor Activity and Discriminates Reversible from Irreversible Agents | 1-gen-2023 | Arafet, Kemel; Scalvini, Laura; Galvani, Francesca; Martí, Sergio; Moliner, Vicent; Mor, Marco; Lodola, Alessio | |
| Mechanistic Modeling of Monoglyceride Lipase Covalent Modification Elucidates the Role of Leaving Group Expulsion and Discriminates Inhibitors with High and Low Potency | 1-gen-2022 | Galvani, F.; Scalvini, L.; Rivara, S.; Lodola, A.; Mor, M. | |
| Molecular Determinants of EphA2 and EphB2 Antagonism Enable the Design of Ligands with Improved Selectivity | 1-gen-2023 | Guidetti, Lorenzo; Zappia, Alfonso; Scalvini, Laura; Ferrari, Francesca Romana; Giorgio, Carmine; Castelli, Riccardo; Galvani, Francesca; Vacondio, Federica; Rivara, Silvia; Mor, Marco; Urbinati, Chiara; Rusnati, Marco; Tognolini, Massimiliano; Lodola, Alessio | |
| Pharmacological characterization of second generation FXR agonists as effective EphA2 antagonists: A successful application of target hopping approach | 1-gen-2023 | Ferrari, Francesca Romana; Giorgio, Carmine; Zappia, Alfonso; Ballabeni, Vigilio; Bertoni, Simona; Barocelli, Elisabetta; Scalvini, Laura; Galvani, Francesca; Mor, Marco; Lodola, Alessio; Tognolini, Massimiliano | |
| Unbinding Kinetics of Muscarinic M3 Receptor Antagonists Explained by Metadynamics Simulations | 1-gen-2023 | Galvani, F.; Pala, D.; Cuzzolin, A.; Scalvini, L.; Lodola, A.; Mor, M.; Rizzi, A. |